pmid,title,journal,year,drug,disease
40134330,A Case Report of Successful Use of Phenytoin/Fosphenytoin in a Pediatric Kidney Transplant Recipient With Nirmatrelvir/Ritonavir-Induced Tacrolimus Allograft Injury.,Pediatric transplantation,2025,Paxlovid,Chronic Kidney Disease
38377093,"Clinical characteristics and risk factors of non-mild outcomes in patients with Omicron variant COVID-19 in Shanghai, China.",Journal of infection in developing countries,2024,Paxlovid,Chronic Kidney Disease
37927438,Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.,The Lancet regional health. Europe,2023,Paxlovid,Chronic Kidney Disease
37369283,Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.,Antiviral research,2023,Paxlovid,Chronic Kidney Disease
37337482,Paxlovid for Treating COVID-19 Patients: A Case-Control Study From Two Hospitals in the Eastern Province of Saudi Arabia.,Cureus,2023,Paxlovid,Chronic Kidney Disease
36843922,How to use COVID-19 antiviral drugs in patients with chronic kidney disease.,Frontiers in pharmacology,2023,Paxlovid,Chronic Kidney Disease
36843224,The effect of nirmatrelvir-ritonavir on viral clearance and length of hospital stay in patients infected with SARS-CoV-2 omicron variants.,Influenza and other respiratory viruses,2023,Paxlovid,Chronic Kidney Disease
36286542,Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis.,Antimicrobial agents and chemotherapy,2022,Paxlovid,Chronic Kidney Disease
35924388,Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave.,Emerging microbes & infections,2022,Paxlovid,Chronic Kidney Disease
